In the ever-evolving landscape of oncology, AKT inhibitors drugs have emerged as a critical component in the fight against various cancers. These drugs target the AKT (Protein Kinase B) signaling pathway, which plays a pivotal role in cell survival, growth, and metabolism. The dysregulation of this pathway is frequently observed in cancer, making AKT inhibitors a promising therapeutic approach....